HIMALAIA (Hypertension Induction in the Management of AneurysmaL subArachnoid haemorrhage with secondary IschaemiA): a randomized single-blind controlled trial of induced hypertension vs. no induced hypertension in the treatment of delayed cerebral ischemia after subarachnoid hemorrhage.

PubWeight™: 0.87‹?›

🔗 View Article (PMID 23692645)

Published in Int J Stroke on May 22, 2013

Authors

C S Gathier1, W M van den Bergh, A J C Slooter, HIMALAIA-Study Group

Author Affiliations

1: Department of Intensive Care, University Medical Centre Utrecht, Utrecht, The Netherlands.

Associated clinical trials:

Induced Hypertension for Treatment of Delayed Cerebral Ischaemia After Aneurysmal Subarachnoid Haemorrhage (HIMALAIA) | NCT01613235

Articles by these authors

Development and validation of PRE-DELIRIC (PREdiction of DELIRium in ICu patients) delirium prediction model for intensive care patients: observational multicentre study. BMJ (2012) 2.34

Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev (2007) 2.08

Dose evaluation for long-term magnesium treatment in aneurysmal subarachnoid haemorrhage. J Clin Pharm Ther (2005) 1.54

Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev (2005) 1.13

Antiplatelet therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev (2007) 1.03

Therapy failure following selection of enfuvirtide-resistant HIV-1 in cerebrospinal fluid. Clin Infect Dis (2010) 1.02

Familial aggregation, the PDE4D gene, and ischemic stroke in a genetically isolated population. Neurology (2005) 0.99

Multinational development and validation of an early prediction model for delirium in ICU patients. Intensive Care Med (2015) 0.89

Delirium in intensive care unit patients. Semin Cardiothorac Vasc Anesth (2010) 0.87

Genes and outcome after aneurysmal subarachnoid haemorrhage. J Neurol (2005) 0.85

High mean fasting glucose levels independently predict poor outcome and delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry (2008) 0.82

An arachnoid cyst presenting as an intramedullary tumour. J Neurol Neurosurg Psychiatry (2000) 0.81

Suppression of cortical spreading depressions after magnesium treatment in the rat. Neuroreport (1998) 0.81

Recovery from near drowning and postanoxic status epilepticus with controlled hypothermia. Neth J Med (2011) 0.80

Light levels of sedation and DSM-5 criteria for delirium. Intensive Care Med (2013) 0.79

Insulin-like growth factor I promoter polymorphism, risk of stroke, and survival after stroke: the Rotterdam study. J Neurol Neurosurg Psychiatry (2006) 0.79

Sleep monitoring by actigraphy in short-stay ICU patients. Crit Care Nurs Q (2013) 0.78

[Delirium in the intensive care unit]. Ned Tijdschr Geneeskd (2008) 0.77

Impact of genetic testing on complex diseases. Eur J Epidemiol (2005) 0.77

Juvenile-onset Alpers syndrome: interpreting MRI findings. Neurology (2010) 0.76

[Coagulation disorders in patients with trauma to the skull and brain: a frequent and potentially fatal combination]. Ned Tijdschr Geneeskd (2007) 0.75

Magnesium and headache after aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry (2009) 0.75

[Diagnostic image (171). A man with a painful red ear. Relapsing polychondritis]. Ned Tijdschr Geneeskd (2004) 0.75

[Recognising postoperative delirium in the elderly]. Ned Tijdschr Geneeskd (2017) 0.75

Classification of daily mental status in critically ill patients for research purposes. J Crit Care (2015) 0.75